Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Retained Earnings (2020 - 2025)

Historic Retained Earnings for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$377.8 million.

  • Insight Molecular Diagnostics' Retained Earnings fell 1917.12% to -$377.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$377.8 million, marking a year-over-year decrease of 1917.12%. This contributed to the annual value of -$350.5 million for FY2024, which is 2092.72% down from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Retained Earnings of -$377.8 million as of Q3 2025, which was down 1917.12% from -$367.0 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Retained Earnings peaked at -$127.6 million during Q1 2021, and registered a low of -$377.8 million during Q3 2025.
  • Moreover, its 5-year median value for Retained Earnings was -$272.5 million (2023), whereas its average is -$263.5 million.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Retained Earnings tumbled by 5525.57% in 2022, and later plummeted by 1120.16% in 2023.
  • Insight Molecular Diagnostics' Retained Earnings (Quarter) stood at -$187.8 million in 2021, then crashed by 38.82% to -$260.7 million in 2022, then dropped by 11.2% to -$289.9 million in 2023, then fell by 20.93% to -$350.5 million in 2024, then dropped by 7.78% to -$377.8 million in 2025.
  • Its Retained Earnings was -$377.8 million in Q3 2025, compared to -$367.0 million in Q2 2025 and -$357.2 million in Q1 2025.